Literature DB >> 9453228

Characterization of nociceptin-stimulated in situ [35S]GTPgammaS binding in comparison with opioid agonist-stimulated ones in brain regions of the mice.

I Shimohira1, S Tokuyama, A Himeno, M Niwa, H Ueda.   

Abstract

We studied the characterization of receptor-mediated G protein activity by nociceptin throughout brain regions, using in situ GTPgammaS binding autoradiography. Nociceptin-stimulated GTPgammaS binding was markedly observed in amygdala, hippocampal pyramidal cell layers, temporal and entorhinal cortex, infralimbic organ, anterior olfactory nucleus, and rostral part of thalamus. These nociceptin-stimulated activities were not affected by naloxone, naltrindol nor norbinaltorphimine which completely blocked mu-, delta- or kappa-opioid agonist-stimulated GTPgammaS binding, respectively. In addition, the distribution of nociceptin-stimulated activities throughout brain regions was found to be different from such opioid receptor-mediated ones.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9453228     DOI: 10.1016/s0304-3940(97)00807-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.

Authors:  M Narita; H Mizoguchi; D E Oji; N J Dun; B H Hwang; H Nagase; L F Tseng
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.

Authors:  H Ueda; M Inoue; H Takeshima; Y Iwasawa
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  Antioscillatory effects of nociceptin/orphanin FQ in synaptic networks of the rat thalamus.

Authors:  Susanne Meis; Thomas Munsch; Hans-Christian Pape
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala.

Authors:  S Meis; H C Pape
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

5.  Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.

Authors:  M Narita; H Mizoguchi; M Narita; I Sora; G R Uhl; L F Tseng
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

6.  A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.

Authors:  F Jenck; J Wichmann; F M Dautzenberg; J L Moreau; A M Ouagazzal; J R Martin; K Lundstrom; A M Cesura; S M Poli; S Roever; S Kolczewski; G Adam; G Kilpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Roles of K+ and cation channels in ORL-1 receptor-mediated depression of neuronal excitability and epileptic activities in the medial entorhinal cortex.

Authors:  Huiming Li; Binqi Hu; Hao-Peng Zhang; Cody A Boyle; Saobo Lei
Journal:  Neuropharmacology       Date:  2019-04-15       Impact factor: 5.250

8.  Postsynaptic mechanisms underlying responsiveness of amygdaloid neurons to nociceptin/orphanin FQ.

Authors:  S Meis; H C Pape
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.